Lv3
390 积分 2024-12-27 加入
接受所有小饼干
Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis
20天前
已完结
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
27天前
已完结
EGFR-mutated NSCLC: A roadmap to treatment sequences
1个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
1个月前
已完结
The global burden of lung cancer: current status and future trends
1个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
3个月前
已完结
Anlotinib plus benmelstobart and chemotherapy are effective in ES-SCLC
3个月前
已完结
皖公网安备34019202002308
